InnAccel
560025 Bangalore, India
InnAccel Company Information
General information
InnAccel is India’s first, and only, Medical Technology Innovation Platform for Global Emerging Markets.
Vision: Global leadership in MedTech innovation for India and Emerging Markets
Mission: Creating the world’s first portfolio of medical products, designed, engineered, and PRICED for Global Emerging Markets
InnAccel identifies critical, unmet, healthcare needs, using the Stanford Biodesign process, and initiates research programs on selected clinical needs with large global markets. The selected needs are taken forward to develop a regulatory-certified, world-class, product, deploying InnAccel’s proprietary Product Engineering & Development (PED) platform, in 2 – 3 years.
InnAccel’s portfolio comprises 5 novel products addressing a global market of >$5 billion, and addresses conditions that lead to almost a million deaths in India alone each year. InnAccel has over 20 professionals (engineers, designers, clinicians) at its Innovation Center, led by a team that brings together entrepreneurial, technology development, and clinical experience. Our strategic advisory board includes industry leaders, and we have a network of 50+ advisors/ mentors to guide project teams.
InnAccel plans to set up 3 Innovation Centers, and initiate over 50 MedTech projects (addressing high-impact, high-value needs), by 2020- enabling us to transform healthcare, and attain global leadership in medical technology for emerging markets, by 2025.
5, Rajaramohun Roy Road, Bangalore
- Opening hours
-
Monday:09:00 - 18:00Tuesday:09:00 - 18:00Wednesday:09:00 - 18:00Thursday:09:00 - 18:00Friday:09:00 - 18:00
- Parking
- The company has a parking lot.
- Phone number
- +918040923864
- Linki
- Social Accounts
- Keywords
- medical technology manufacturer
InnAccel Reviews & Ratings
How do you rate this company?
Are you the owner of this company? If so, do not lose the opportunity to update your company's profile, add products, offers and higher position in search engines.